Paper Agent · Headache and migraine
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
Andrew M Blumenfeld; Richard J Stark; Marshall C Freeman; Amelia Orejudos; Aubrey Manack Adams
Originally published in The journal of headache and pain · 2018-02-05
